EVOTEC SE INH O.N./ DE0005664809 /
03/09/2024 20:17:40 | Chg. -0.410 | Volume | Bid20:17:41 | Ask20:17:41 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
6.225EUR | -6.18% | 387,845 Turnover: 2.47 mill. |
6.225Bid Size: 1,500 | 6.270Ask Size: 1,500 | 1.1 bill.EUR | - | - |
GlobeNewswire
11/12/2023
Glycotope and Evotec enter licensing agreement to combine Glycotope antibodies and Evotec’s immune c...
GlobeNewswire
07/11/2023
Dewpoint Therapeutics Enters Strategic Partnership with Evotec to Accelerate Oncology Pipeline
GlobeNewswire
15/02/2018
EVOTEC AG AND MARS INNOVATION ANNOUNCE FIRST FUNDED PROJECT UNDER LAB150 BRIDGE
GlobeNewswire
08/01/2018
APEIRON and Evotec Achieve First Milestone in Immuno-oncology Alliance with Sanofi
GlobeNewswire
14/09/2017
MARS INNOVATION AND EVOTEC AG ESTABLISH ACADEMIC BRIDGE “LAB150” IN TORONTO
GlobeNewswire
29/11/2011
Directors' dealings:Evotec AG:Director's Dealings announcement according to §15a WpHG (the German Se...
GlobeNewswire
27/10/2011
Evotec Achieves Two Milestones in Fragment-based Drug Discovery Alliance with Shionogi
GlobeNewswire
09/09/2011
Directors' dealings:Evotec AG:Director's Dealings announcement according to §15a WpHG (the German Se...
GlobeNewswire
05/09/2011
Evotec and Roche agree to develop compound that could slow the progression of Alzheimer's disease
GlobeNewswire
05/09/2011
Evotec AG:Ad hoc:Evotec and Roche agree to develop compound that could slow the progression of Alzhe...
GlobeNewswire
18/08/2011
Evotec Receives Pre-clinical Milestone Payment as Part of its Discovery Alliance with Boehringer In...
GlobeNewswire
11/08/2011
Evotec reports 34% revenue and profitable earnings growth; revenue guidance raised
GlobeNewswire
11/08/2011
Evotec partners P2X7 antagonist programme, EVT 401, to a top tier global animal health company
GlobeNewswire
07/07/2011
Evotec announces multi-target collaboration with UCB in neurodegenerative and neurological diseases